BSUG Actions following the Recommendations of the IMMDS Review
Following the publication of the IMMDS Report on the 8th July, the British Society of Urogynaecology have had an opportunity to deliberate and take steps to address the recommendations. There are obviously some recommendations that are out with our remit but we would like share what we are doing. We wish to make this an open and transparent process and ensure patients and public bodies have access to any actions taken. By doing so we hope to demonstrate our commitment to ensuring that all recommendations are met in a timely manner to the satisfaction of patients who have suffered harm from the use of mesh. Download further information here
BSUG apology in response to the Report of Independent Medicines and Medical Devices Safety Review
Dr Swati Jha, Chair of BSUG, said:
“BSUG wishes to offer its heartfelt regret and apologise for the considerable harm women have experienced from the use of mesh for the treatment of pelvic organ prolapse and urinary incontinence. We know this has had a profound effect on women’s physical health and mental wellbeing.
On behalf of the profession, we are sorry women were not listened to and wish to work with women to address their concerns.
We are reflecting on how our organisation can work closely with women to repair lost trust and ensure that we make the right changes to protect all of our patients in the future. We will be taking forward the recommendations made in the report.
The aims of BSUG is to encourage the study and management of female pelvic floor dysfunction, urinary incontinence, pelvic organ prolapse and faecal incontinence. We will continue to offer training , education and research that enhances the care of women.”
England Mesh Complication Centres Announced
NHS England and NHS Improvement are responsible for commissioning specialised services for women with complications of mesh inserted for urinary incontinence and vaginal prolapse. Following the initial public consultation of the new service specification in 2018, we have undertaken a provider selection exercise and can now share which hospitals will be leading the multidisciplinary teams (MDTs) providing this specialist service.